“…Similarly to what was seen for overall AVB, the incidence of high-grade AVB was significantly higher in studies using adenosine compared to regadenoson (5.21%; 95% CI 2.81%–8.30% vs 0.05%; 95% CI < 0.001%–0.19% respectively, P < .001, OR 77.2; 95% CI 20.3–293.0). No cases of SA node dysfunction were reported in any of the studies using regadenoson, as opposed to the ones using adenosine, with the majority being cases of bradycardia 3,29,38,43 and very few cases of transient sinoatrial block, 42 sinus pause 29,39 and only one case of asystole seen in the small study of nonagenarians. 31 Neither mean (or median) patient age nor prior history of diabetes, examined as covariates, exhibited significant association with rates of de novo AVB.…”